PPBT - Purple Biotech - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PPBT is currently covered by 1 analysts with an average price target of $-61.44. This is a potential upside of $-65.55 (-1594.89%) from yesterday's end of day stock price of $4.11.

Purple Biotech's activity chart (see below) currently has 16 price targets and 18 ratings on display. The stock rating distribution of PPBT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.17% with an average time for these price targets to be met of 201.25 days.

Highest price target for PPBT is $34, Lowest price target is $34, average price target is $34.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 30-May-2025. First documented stock forecast 21-Nov-2017.

Best performing analysts who are covering PPBT - Purple Biotech:

Matthew Barcus Emily Bodnar Raghuram Selvaraju Catherine Novack

Currently out of the existing stock ratings of PPBT, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Oct-2022

$34

$29.89 (727.25%)

$33

10 months 6 days ago
(30-May-2025)

8/12 (66.67%)

$8 (30.77%)

248

Buy Since 21-Jul-2023

$60

$55.99 (1396.26%)

$3200

1 years 10 months 2 days ago
(03-Jun-2024)

1/2 (50%)

$-88 (-59.46%)

113

Buy Since 08-Feb-2023

$220

$215.89 (5252.80%)

$220

2 years 10 months 19 days ago
(17-May-2023)

2/2 (100%)

$-157 (-41.64%)

124

Buy Since 21-Nov-2017

$60

$56.02 (1407.54%)

$60

5 years 6 months 8 days ago
(28-Sep-2020)

5/5 (100%)

$-25.2 (-29.58%)

320

Show more analysts

Please expand the browser size to see the chart

What is PPBT (Purple Biotech) average time for price targets to be met?

On average it took 201.25 days on average for the stock forecasts to be realized with a an average price target met ratio 79.17

Which analyst has the current highest performing score on PPBT (Purple Biotech) with a proven track record?

MATTHEW BARCUS

Which analyst has the current lower performing score on PPBT (Purple Biotech) with a proven track record?

CATHERINE NOVACK

Which analyst has the most public recommendations on PPBT (Purple Biotech)?

Matthew Barcus has 3 price targets and 3 ratings on PPBT

Which analyst is the currently most bullish on PPBT (Purple Biotech)?

Matthew Barcus with highest potential upside - $215.89

Which analyst is the currently most reserved on PPBT (Purple Biotech)?

Emily Bodnar with lowest potential downside - $29.89

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?